Prophylactic cancer vaccination by targeting functional non-self

Annals of Medicine

Volumn 43, Issue 5, 2011, Pages 356-365

  Tuohy, Vincent K ^a,b   Jaini, Ritika ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune; cancer vaccine; tumor immunotherapy

Indexed keywords

CANCER VACCINE;

ARTICLE; BREAST CANCER; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CANCER SURVIVAL; DRUG MECHANISM; DRUG TARGETING; HUMAN; NEOPLASM; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; ANIMALS; BREAST NEOPLASMS; CANCER VACCINES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 79959370408     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.565065     Document Type: Article

References (76)

1. Centers for Disease Control and Prevention. Ten great public health achievements - United States, 1900-1999. Morb Mortal Wkly Rep. 1999;48:241-3.
2. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children - United States, 1990-1998. Morb Mortal Wkly Rep. 1999;48:243-8.
3. Centers for Disease Control and Prevention. Recommendations and guidelines 2011 child and adolescent immunization schedules. Available at: http://www.cdc.gov/vaccines/recs/schedules/ child-schedule.htm (Last accessed 11 March 2011).
4. National Network for Immunization Information (NNii). Vaccines: Hib. 2007. Available at: http://www.immunizationinfo. org/vaccines/haemophilus- influenzae-type-b-hib (Last accessed 11 March 2011).
5. National Network for Immunization Information (NNii). Vaccines: diphtheria, tetanus, pertussis (DTaP). 2009. Available at: http://www. immunizationinfo.org/vaccines/tetanus (Last accessed 11 March 2011).
6. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155-63. (Pubitemid 350106654)
7. Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, et al.; Costa Rican HPV Vaccine Trial Group. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743-53. (Pubitemid 47263157)
8. Jackson AC. Rabies virus infection: an update. Neurovirol. 2003;9:253-8. (Pubitemid 36656459)
9. Rosenberg SA, Yang JC. Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004;10: 909-15. (Pubitemid 39273730)
10. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al.; IMPACT Study Investigators. Sipuleucel- T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411-22.
11. McCaughtry TM, Baldwin TA, Wilken MS, Hogquist KA. Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J Exp Med. 2008; 205: 2575-84.
12. Nitta T, Murata S, Ueno T, Tanaka K, Takahama Y. Thymic microenvironments for T-cell repertoire formation. Adv Immunol. 2008;99:59-94.
13. Rubin SC, Finstad CL, Federici MG, Scheiner L, Lloyd KO, Hoskins WJ. Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer. Cancer. 1994;73:1456-9. (Pubitemid 24072553)
14. Serrano-Olvera A, Duenas-Gonzalez A, Gallardo-Rincon D, Candelaria M, De la Garza-Salazar J. Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer. Cancer Treat Rev. 2006;32:180-90.
15. Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, et al. The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist. 2003;8: 307-25. (Pubitemid 36929717)
16. Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res. 2003;9:1837-49. (Pubitemid 36554612)
17. Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res. 2008; 68:861-9. (Pubitemid 351206764)
18. Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267-96. (Pubitemid 46697910)
19. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA. 1994; 91:3515-9. (Pubitemid 24139460)
20. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850-4. (Pubitemid 35231542)
21. Hodi FS, O' D ay SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363:711-23.
22. U.S. Food and Drug Administration. Vaccines, Blood, and Biologics. Approval Letter - Provenge. 29 April 2010. Available at: http://www.fda.gov/ BiologicsBloodVaccines/ CellularGeneTherapyProducts/ApprovedProducts/ ucm210215.htm (Last accessed 11 March 2011).
23. Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, et al. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol. 2006;24: 3089-94. (Pubitemid 46638945)
24. Cheng MH, Shum AK, Anderson MS. What' s new in the Aire? Trends Immunol. 2007;28:321-7.
25. Tykocinski LO, Sinemus A, Kyewski B. The thymus medulla slowly yields its secrets. Ann NY Acad Sci. 2008;1143: 105-22.
26. Mathis D, Benoist C. Aire. Annu Rev Immunol. 2009;27: 287-312.
27. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol. 2009;21:281-5.
28. Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med. 2000;6:56-61. (Pubitemid 30048526)
29. Harrington CJ, Paez A, Hunkapiller T, Mannikko V, Brabb T, Ahearn M, et al. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity. 1998;8:571-80. (Pubitemid 28264748)
30. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;89:12-19. (Pubitemid 29406813)
31. Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278-85. (Pubitemid 38924707)
32. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907. (Pubitemid 47371147)
33. D 'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356: 1944-56. (Pubitemid 46740304)
34. Harper DM. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health. Public Health Genomics. 2009;12:319-30.
35. Marur S, D' Souza G, Westra WH, Forastiere AA. HPVassociated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781-9.
36. Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health. 2010;7:244-52.
37. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797-801. (Pubitemid 23174709)
38. Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, et al.; Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 1997;336:1855-9. (Pubitemid 27263972)
39. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine. 1996;14:1019-27. (Pubitemid 26281288)
40. Pattle SB, Farrell PJ. The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther. 2006;6:1193-205. (Pubitemid 44714145)
41. Beral V, Newton R, Sitas F. Human Herpesvirus 8 and Cancer. J Nat Cancer Inst. 1999;91:1440-1. (Pubitemid 29424547)
42. Franchini G, Nicot C, Johnson JM. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res. 2003;89:69-132. (Pubitemid 41184280)
43. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA. 2007;104:1655-60. (Pubitemid 46214646)
44. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA. 2009;106:16351-6.
45. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, et al. XMRV: a new virus in prostate cancer? Cancer Res. 2010;70:10028-33.
46. Stoye JP, Silverman RH, Boucher CA, Le Grice SF. The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop. Retrovirology. 2010;7:113.
47. P arsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-31.
48. Ponta H, Gonzburg WH, Salmons B, Groner B, Herrlich P. Mouse mammary tumour virus: A proviral gene contributes to the understanding of eukaryotic gene expres-sion and mammary tumorigenesis. J Gen Virol. 1985;66:931-43.
49. Holland JF, Pogo BG. Mouse mammary tumor virus-like viral infection and human breast cancer. Clin Cancer Res. 2004;10:5647-9. (Pubitemid 39180937)
50. Pogo BG, Holland JF, Levine PH. Human mammary tumor virus in infl ammatory breast cancer. Cancer. 2010;116(11 Suppl):2741-4.
51. Szabo S, Haislip AM, Traina-Dorge V, Costin JM, Crawford BE 2nd, Wilson RB, et al. Human, rhesus macaque, and feline sequences highly similar to mouse mammary tumorvirus sequences. Microsc Res Tech. 2005;68:209-21. (Pubitemid 41696970)
52. Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol. 2008;82:9329-36.
53. Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, et al. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 2008;10:521-33. (Pubitemid 351770296)
54. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 2008;68:5869-77.
55. Stewart TH, Sage RD, Stewart AF, Cameron DW. Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus. Br J Cancer. 2000;82:446-51. (Pubitemid 30045396)
56. Indik S, Günzburg WH, Salmons B, Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res. 2005;65:6651-9. (Pubitemid 41060701)
57. Rollison DE. JC Virus infection a cause of colorectal cancer? J Clin Gastroent. 2010;44:466-8.
58. Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK. An autoimmune-mediated strategy for pro phylactic breast cancer vaccination. Nat Med. 2010;16:799-803.
59. International Agency for Research on Cancer, World Health Organizaion, GLOBOCAN 2008. Breast cancer incidence and mortality worldwide in 2008. Available at: http://globocan. iarc.fr/factsheets/cancers/breast.asp#MORTALITY (Last accessed 11 March 2011).
60. Hall L, Craig RK, Davies MS, Ralphs DN, Campbell PN. Lactalbumin is not a marker of human hormonedependent breast cancer. Nature. 1981;290:602-4. (Pubitemid 11092375)
61. Bailey AJ, Sloane JP, Trickey BS, Ormerod MG. An immunocytochemical study of -lactalbumin in human breast tissue. J Pathol. 1982;137:13-23. (Pubitemid 12122234)
62. Clayton F, Sibley RK, Ordonez NG, Hanssen G. Argyrophilic breast carcinomas: evidence of lactational differentiation. Am J Surg Pathol. 1982;6:323-33. (Pubitemid 12069167)
63. Lee AK, DeLellis RA, Rosen PP, Herbert-Stanton T, Tallberg K, Garcia C, et al. Alpha-lactalbumin as an immunohistochemical marker for metastatic breast carcinomas. Am J Surg Pathol. 1984;8:93-100. (Pubitemid 14196540)
64. Lee AK, Rosen PP, DeLellis RA, Saigo PE, Gangi MD, Groshen S, et al. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am J Clin Pathol. 1985;84:687-96. (Pubitemid 16213280)
65. Cohen C, Sharkey FE, Shulman G, Uthman EO, Budgeon LR. Tumor associated antigens in breast carcinomas. Prognostic significance. Cancer. 1987;60:1294-8. (Pubitemid 17152909)
66. Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G, Spona J. Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract. 1988; 183:277-83.
67. Martin RH, Glass MR, Chapman C, Wilson GD, Woods KL. Suppression by bromocriptine of the serum lactalbumin peak associated with human lactogenesis. Clin Endocrinol (Oxf). 1981;14:363-6. (Pubitemid 11053556)
68. Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, et al. Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alphalactalbumin promoter. Mol Cancer Ther. 2005;4:1850-9. (Pubitemid 43056968)
69. Anderson LM, Swaminathan S, Zackon I, Tajuddin AK, Thimmapaya B, Weitzman SA. Adenovirus-mediated tissuetargeted expression of the HSVtk gene for the treatment of breast cancer. Gene Ther. 1999;6:854-64. (Pubitemid 29243660)
70. Anderson LM, Krotz S, Weitzman SA, Thimmapaya B. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Cancer Gene Ther. 2000;7:845-52. (Pubitemid 30437284)
71. Nagamatsu Y, Oka T. Purification and characterization of mouse lactalbumin and preparation of its antibody. Biochem J. 1980;185:227-37. (Pubitemid 10182862)
72. Ren J, Stuart DI, Acharya KR. α-lactalbumin possesses a distinct zinc binding site. J Biol Chem. 1993;268:19292-8. (Pubitemid 23270701)
73. Vilotte JL, Soulier S. Isolation and characterization of the mouse α-lactalbumin-encoding gene: interspecies comparison, tissue-and stage-specific expression. Gene. 1992;119:287-92.
74. Vilotte JL, Soulier S, Mercier JC. Sequence of the murine α-lactalbumin-encoding cDNA: interspecies comparison of the coding frame and deduced preprotein. Gene. 1992; 112:251-5.
75. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA. 1992;89:10578-82.
76. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992;12:954-61.